Close Menu

HIV

Scientists from PATH and the US Centers for Disease Control will collaborate under a three-year grant from the National Institutes of Health to further develop and test a non-instrumented DNA amplification kit for diagnosing diseases in resource-poor areas of the world, according

By Adam Bonislawski
Virginia Tech scientists have developed an algorithm that uses protein interaction data to make predictions about the function of individual molecules.

This story has been updated to correct a statement regarding H1 revenues from NextGen's biomarker qualification panels.

By Ben Butkus
Clinical diagnostic test maker Iquum this week received US Food and Drug Administration clearance for its Liat Influenza A/B assay and fully automated and integrated Liat Analyzer.

The NextGen Group said this week its US subsidiary NextGen Sciences has signed a deal with the University of Nebraska for use of its csfdiscovery43 biomarker discovery assay.

By Monica Heger
This story, originally published Aug. 16, has been updated to clarify information about the performance of the company's tests.

Pages

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.